SEI Medical PCL

SEI Medical PCL EBIT per Share

The EBIT per Share of SEI Medical PCL (SEI.BK) as of Oct 26, 2026 is 0.34 THB. In the previous year, EBIT per Share was 0.38 THB — a change of -11.81% (lower).

EBIT per Share

0.34THB

YoY

-11.81%

Last updated:

EBIT per Share of SEI Medical PCL is 2025 0.34 THB. EBIT per Share of SEI Medical PCL was 2024 0.38 THB. It decreases by -11.81% lower compared to the previous year.

The SEI Medical PCL EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
0.14 THB
Jan 1, 2023
0.18 THB
Jan 1, 2024
0.38 THB
Jan 1, 2025
0.34 THB
Jan 1, 2026 (e)
0.00 THB
Jan 1, 2027 (e)
0.00 THB
The SEI Medical PCL EBIT per Share history
YEAREBIT per ShareYoY
est0.00THB—
est0.00THB-100.00%
0.34THB-11.81%
0.38THB+117.86%
0.18THB+28.63%
0.14THB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SEI Medical PCL Stock analysis

What does SEI Medical PCL do? SEI Medical PCL generates revenue through the distribution and leasing of medical equipment and laboratory instruments. The company's primary products include endoscopy equipment, surgical equipment, aesthetic equipment, neonatal care equipment, and laboratory equipment, sold across its Scientific equipment and medical equipment segments. Service contracts form another key revenue stream, covering maintenance and support for medical devices. The firm serves healthcare providers and institutions requiring diagnostic and treatment solutions, leveraging its Bangkok headquarters to operate within Thailand's medical sector. The company's business model focuses on selling scientific and medical equipment, offering service contracts, and providing medical equipment lease agreements. Its segments are clearly defined as Scientific equipment and medical equipment, with service as a separate offering. Revenue is derived from direct sales to hospitals, clinics, and laboratories, as well as from long-term lease contracts. The firm's IPO on September 24, 2024, marks its entry into public markets, though it continues to rely on its established distribution network for growth. SEI Medical PCL's core operations involve the sale of specialized medical equipment including endoscopy, surgical, and neonatal care devices, alongside laboratory instruments. The service segment provides essential maintenance and technical support, enhancing customer retention. The company targets healthcare facilities seeking comprehensive solutions for diagnostic and therapeutic procedures, positioning itself as a key supplier in Thailand's medical equipment market. SEI Medical PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SEI Medical PCL stock

EBIT per Share of SEI Medical PCL is 0.34 THB in 2025.

EBIT per Share of SEI Medical PCL changed from 0.38 THB to 0.34 THB, representing a -11.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share SEI Medical PCL since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — SEI Medical PCL

All Key Metrics — SEI Medical PCL